Meet Cromos Pharma’s CEO, Dr. Vlad Bogin in San Antonio, Texas at San Antonio Breast Cancer Symposium (SABCS 2016) on December 6-10, 2016

Cromos Pharma’s CEO Dr. Vlad Bogin has joined the board of directors of Batu Biologics

Cromos Pharma’s CEO Dr. Vlad Bogin has joined the board of directors of Batu Biologics, a biotechnology-based pharmaceutical company focused on the development and commercialization of novel ‎cancer treatments.

CONTACT

BD@CROMOSPHARMA.COM

To arrange an introductory meeting and find out how our experience can benefit your next clinical project.

NEWS

EVENTS

August is Immunization Awareness Month
Decentralized Clinical Trials. What does the future hold?
Cromos Pharma Highlights Psoriasis Awareness and Action Month
Monkeypox was Declared a Global Health Emergency by WHO
Patients’ Portal: New Languages added
Key Takeaways from the BIO International Convention 2022
Key Takeaways from the BIO International Convention 2022
Key Takeaways from ASCO Annual Meeting 2022
patient centricity
Cromos Pharma Committed to Patient Centricity in Clinical Trials
Cromos Pharma's CEO Vlad Bogin's interview at the National Desk, An Unseen Cost of the Ukraine War,
An Unseen Cost of the Ukraine War
Cromos Pharma Names New Head of Feasibility and Therapeutic Strategy Bulgun Margaeva
Cromos Pharma Names New Head of Feasibility and Therapeutic Strategy
Cromos Pharma Names New Country Head in Poland, bozeba sasorska
Cromos Pharma Names New Country Head in Poland
Meet Cromos Pharma at the BIO International Convention 2022
Meet Cromos Pharma at the BIO International Convention 2022
Meet Cromos Pharma at ASCO Annual Meeting 2022, US-based clinical research organisation
Meet Cromos Pharma at ASCO Annual Meeting 2022
Clinical Trials Disrupted During War in Ukraine, Clinical Trials in Ukraine
Clinical Trials Disrupted During War in Ukraine
clinical trials in central & easter europe, Company facts,
Cromos Pharma’s Clinical Research Focus March 2022
US and Europe biosimilars, clinical trials in EU & US
Patient recruitment challenges for clinical trials
clinical trials in central & easter europe, Meet Cromos Pharma at SCOPE 2022,
Key takeaways from Scope 2022
The role of decentralized approaches in clinical trials, clinical trials phases
The role of decentralized approaches in clinical trials
7 steps for successful clinical trial protocol design,
7 steps for successful clinical trial protocol design
European medicines agencies launch public consultation on joint strategy
A new era for clinical trials in Europe
Cromos Pharma launches clinical research focus newsletter
Cromos Pharma launches clinical research focus newsletter
"No Patients - No Payment" risk-sharing program explained
“No Patients – No Payment” risk-sharing program explained
Cromos Pharma on clinical trial trends for 2022,
Cromos Pharma on clinical trial trends for 2022
clinical trials in central & easter europe, Meet Cromos Pharma at SCOPE 2022,
Meet Cromos Pharma at SCOPE 2022
Cromos named top Quality Assurance service provider by Pharma Tech Outlook
Cromos named top Quality Assurance service provider by Pharma Tech Outlook
clinical trials in central & easter europe, Company facts,
Connect with Cromos Pharma at the 40th JP Morgan Healthcare Conference
Cromos Pharma supporting clinical trials to advance HIV treatments, US-based clinical research organisation,
Cromos Pharma supporting clinical trials to advance HIV treatments
eCONSENT and clinical trials
eCONSENT and clinical trials
Cromos Pharma delivering high quality data for clinical trial success
Cromos Pharma delivering high quality data for clinical trial success
Meet with Cromos Pharma during the San Antonio Breast Cancer Symposium
Meet with Cromos Pharma during the San Antonio Breast Cancer Symposium